FLAG-003

N/A

Report date: 2025/01/26 16:30:23
NME

Base Information

Drug NameFLAG-003
Drug Alias Nametubulin/angiogenic antagonists (FLAG Therapeutics)FLAG-003
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTubulin inhibitorsNerve growth factor receptor Trk-A degraders
TargetsTubulinNerve growth factor receptor Trk-A
Therapy Area/IndicationsGlioblastomaGliomaNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesEurope
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDuquesne University
China Registration ClassN/A

Develop Information

Active CompaniesFLAG Therapeutics Inc
Inactive CompaniesDuquesne University
Active IndicationsGlioblastomaGlioma
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A